    Joan Stafslien | CareFusion | ZoomInfo.com










 




Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Joan B. Stafslien Esq.: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 5:16 PM ET
Health Care Technology

Company Overview of Millennium Health, LLC



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Joan B. Stafslien Esq.Director, Millennium Health, LLCAgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.See Board Relationships52--
Background

		Ms. Joan B. Stafslien, Esq. served as an Executive Vice President and General Counsel of NuVasive, Inc. since October 3, 2016 until July 13, 2017 and served as Company Secretary since October 7, 2016 until July 13, 2017. Ms. Stafslien served as an Interim General Counsel of NuVasive, Inc. from August 01, 2016 to October 3, 2016. Ms. Stafslien served as an Executive Vice President, General Counsel and Secretary of CareFusion Corporation since August 2009 and served as ... its Chief Compliance Officer from June 2010 to February 2014. Ms. Stafslien served as the Senior Vice President and General Counsel, Clinical and Medical Products Business Segment at Cardinal Health since July 2008. She served as Senior Vice President and General Counsel, Clinical Technologies and Services of Cardinal Health, from August 2004 to July 2008. From March 1999 to August 2004, she served as Deputy General Counsel and Assistant General Counsel of Alaris Medical Systems. From May 1998 to February 1999, she served as Senior Corporate Counsel to Alaris Medical Systems. She served as an Associate with the law firms of Brobeck, Phleger & Harrison LLP and Luce, Forward, Hamilton & Scripps LLP. She worked at The Dow Chemical Company as a Chemical Engineer and in sales roles. She has been a Director of Millennium Health, LLC since August 01, 2016. She sits on the board for Northwestern University Chemical and Biological Engineering Department, Santa Fe Christian Schools and John Brockington Foundation. She holds a bachelor's of science degree in chemical engineering from Northwestern University and a Juris Doctorate from University of Wisconsin -Madison Law School.Read Full Background




Corporate Headquarters
16981 Via TazonSan Diego, California 92127United StatesPhone: 858-451-3535Fax: 858-451-3636
Board Members Memberships
2016-PresentDirectorMillennium Health, LLC
Education
JD University of Wisconsin - MadisonBS Northwestern University
Other Affiliations
NuVasive, Inc.University of Wisconsin - MadisonNorthwestern UniversityCareFusion Corporation


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Millennium Health, LLC, please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





































NuVasive Appoints Joan Stafslien As Executive Vice President, General Counsel | NuVasive







































 













Search for:






search
Created with Sketch.

















Menu










NuVasive























By Andrew Nurre
12:00 AM on October, 3 2016

NuVasive Appoints Joan Stafslien As Executive Vice President, General Counsel


SAN DIEGO, CA – October 3, 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced Joan Stafslien is joining the Company as executive vice president, general counsel and corporate secretary. In this role, Ms. Stafslien will oversee the Company’s global legal function, reporting to NuVasive’s chairman and chief executive officer, Gregory T. Lucier, and serving on the company’s executive leadership team.
Ms. Stafslien brings to NuVasive more than 20 years of experience as a legal advisor to medical technology companies. She joins NuVasive from CareFusion, where she served as general counsel and corporate secretary from 2009 until its acquisition by Becton Dickinson in 2015.
“Joan’s experience spans a broad spectrum of legal areas, including intellectual property, U.S. and International litigation, regulatory compliance, SEC matters and M&A, with extensive experience in the global medical technology sector,” said Mr. Lucier. “Joan’s understanding of complex medical technology companies on high growth trajectories makes her a perfect fit with the strong foundation we have established with our legal team. We continue to invest in building a world-class leadership team to support our growing innovation position in the global spine market.”
Ms. Stafslien’s career includes law firm and corporate experience. She previously served as CareFusion’s general counsel, corporate secretary and chief compliance officer where she led the legal team through the spin-off from Cardinal Health in 2009 and the acquisition by Becton Dickinson in 2015. Previously, she was the segment general counsel of Cardinal Health’s Clinical Technologies and Services from 2004 to 2009. Ms. Stafslien joined Cardinal Health through the acquisition of Alaris Medical Systems in 2004, where she served as deputy general counsel and assistant secretary. Prior to joining Alaris, she was in private practice with Brobeck, Phleger & Harrison. Ms. Stafslien serves on the advisory board of the Chemical and Biological Engineering Department of Northwestern University. She holds a law degree from University of Wisconsin Law School and a bachelor’s degree in Chemical Engineering from Northwestern University.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive’s highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $811 million in revenues (2015), NuVasive has an approximate 1,900 person workforce in more than 40 countries around the world. For more information, please visit nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products (including the iGA™ platform), the Company’s ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
# # #
Investor Contact:
Suzanne Hatcher
NuVasive, Inc.
858-458-2240
[email protected]
 
Media Contact:
Michael Farrington
NuVasive, Inc.
858-909-1940
[email protected]

Previous PostNext Post





Share

twitter
facebook
linkedin
googleplus
email

















The materials on this website are for your general educational information only. Information you read on this website cannot replace the relationship that you have with your healthcare professional. We do not practice medicine or provide medical services or advice as a part of this website. You should always talk to your healthcare professional for diagnosis and treatment. 




Terms & Conditions
Privacy
©2017 NuVasive®, Inc.








This site uses cookies to enhance your experience.
OK
Learn More












Solutions

Procedurally-Integrated SolutionsiGA®NVM5®NuVasive Clinical Services™NuVasive Specialized Orthopedics™LessRay® Back
Procedures

Spine

XLIF®XLIF CorpectomyPCFACDFMAS® PLIFMAS TLIFALIFMAGEC® SystemThoracolumbar Posterior Fixation Back 
Limb Lengthening

PRECICE® System Back 
Featured Offerings

BiologicsBendini®RELINE® Back 
 Back
Conditions

Spine

Lumbar Degenerative Disc DiseaseLumbar Spinal StenosisDegenerative SpondylolisthesisDegenerative ScoliosisCervical Disc DegenerationBack PainEarly Onset Scoliosis Back 
Femur / Tibia

Limb Length Discrepancy Back 
 Back
Resources

For Patients

The Better Way Back™SpineTRACK Registry Back 
For Surgeons

Education & TrainingReimbursementElectronic IFU InformationVirtual Patent MarkingSpineTRACK RegistryPCM Data Collection FormNuvaMap®PRECICE Physicians Back 
 Back
ServicesAbout

LeadershipNews & EventsCorporate IntegrityNuVasive Spine FoundationNuVasive Corporate Grants Back
CareersInvestor Relations

Online IR KitFAQsPress ReleasesWebcasts and EventsStock InformationGovernanceSEC FilingsAnnual Reports Back
Electronic IFU InformationContactInternational Sites

NuVasive® JapanNuVasive® Germany Back
 


























Joan Stafslien | NuVasive



































 













Search for:






search
Created with Sketch.

















Menu










NuVasive























By Andrew Nurre
2:41 PM on January, 3 2017

Joan Stafslien


Joan Stafslien, Esq. serves as our Executive Vice President, General Counsel and Corporate Secretary.
Her previous roles include General Counsel, Corporate Secretary and Chief Compliance Officer at CareFusion; Segment General Counsel of Cardinal Health’s Clinical Technologies and Services; and Deputy General Counsel and Assistant Secretary of Alaris Medical Systems. Prior to joining Alaris, Ms. Stafslien was in private practice with Brobeck, Phleger & Harrison. Ms. Stafslien serves on the advisory board of the Chemical and Biological Engineering Department of Northwestern University and received a JD from University of Wisconsin Law School and a B.S. in Chemical Engineering from Northwestern University.

Previous PostNext Post





Share

twitter
facebook
linkedin
googleplus
email

















The materials on this website are for your general educational information only. Information you read on this website cannot replace the relationship that you have with your healthcare professional. We do not practice medicine or provide medical services or advice as a part of this website. You should always talk to your healthcare professional for diagnosis and treatment. 




Terms & Conditions
Privacy
©2017 NuVasive®, Inc.








This site uses cookies to enhance your experience.
OK
Learn More












Solutions

Procedurally-Integrated SolutionsiGA®NVM5®NuVasive Clinical Services™NuVasive Specialized Orthopedics™LessRay® Back
Procedures

Spine

XLIF®XLIF CorpectomyPCFACDFMAS® PLIFMAS TLIFALIFMAGEC® SystemThoracolumbar Posterior Fixation Back 
Limb Lengthening

PRECICE® System Back 
Featured Offerings

BiologicsBendini®RELINE® Back 
 Back
Conditions

Spine

Lumbar Degenerative Disc DiseaseLumbar Spinal StenosisDegenerative SpondylolisthesisDegenerative ScoliosisCervical Disc DegenerationBack PainEarly Onset Scoliosis Back 
Femur / Tibia

Limb Length Discrepancy Back 
 Back
Resources

For Patients

The Better Way Back™SpineTRACK Registry Back 
For Surgeons

Education & TrainingReimbursementElectronic IFU InformationVirtual Patent MarkingSpineTRACK RegistryPCM Data Collection FormNuvaMap®PRECICE Physicians Back 
 Back
ServicesAbout

LeadershipNews & EventsCorporate IntegrityNuVasive Spine FoundationNuVasive Corporate Grants Back
CareersInvestor Relations

Online IR KitFAQsPress ReleasesWebcasts and EventsStock InformationGovernanceSEC FilingsAnnual Reports Back
Electronic IFU InformationContactInternational Sites

NuVasive® JapanNuVasive® Germany Back
 

















San Diego Source > Newsmakers > Joan  Stafslien
















































































						
						Fri July 28, 2017
					




Follow:









Login












The San Diego Source | The Daily Transcript is San Diego's only information company offering business news, data and resources daily and hourly. We report on San Diego business, finance and the San Diego economy, real estate, construction, the U.S. military in San Diego, and San Diego government construction bids.











Newsmakers

				San Diego Newsmakers profiles the people who helped make this region and The Daily Transcript what it is today - a Who's Who of those who have put San Diego County on the map as a thriving region.
			



Joan  Stafslien
Executive VP

CareFusion Corp.


Sourcebook Company Profile
http://www.carefusion.com



3750 Torrey View Ct.
San DiegoCA92130
Map




×
Map: CareFusion Corp.












	As CareFusion (NYSE: CFN) continues to expand its international reach, ramp up innovation and strengthen its operational foundation, Joan Stafslien’s role within the company continues to grow.

	Stafslien handles legal matters for the company on a global basis. She serves as executive vice president, chief compliance officer, general counsel and secretary for the medical device company.


The Daily Transcript's Profiles


In-house counsel for medical giant helping company grow globally

San Diego-based CareFusion manufactures health care products aimed at reducing medical errors and related costs, and helping to prevent health care-associated infections in hospitals.




In-house counsel helps global firm move forward in health care

As CareFusion (NYSE: CFN) continues to expand its international reach, ramp up innovation and strengthen its operational foundation, Joan Stafslien’s role within the company continues to grow.









Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z


Sector
Art
Biotech
Biotechnology
Business Services
Construction
Defense
Education
Finance
Government
Green
Health
Hospitality
Law
Real Estate
Technology







Search Contacts





Search














Interview with Jody Watkins





Clark Pacific's president on his company's history





Interview with Josh Buchholz





Interview with Wells Fargo's Celia Lanning





Interview with Marc Doss





Interview with Don Clark







Sponsors







































Media






Interview with Jody Watkins


	Jody Watkins, president and CEO of Watkins Landmark Construction, talks about business fluctuations in the construction industry and outlines his goals for growing his firm.








Clark Pacific's president on his company's history


	George Chamberlin speaks with Don Clark, president of Clark Pacific, about the more than 50-year history of his company and how it's remained successful through tough economic times.








Interview with Josh Buchholz


	Josh Buchholz, senior vice president of NAI San Diego, discusses the types of services the commercial brokerage and property management company offers and describes what sets his firm apart from the competition.








Interview with Wells Fargo's Celia Lanning


	July 1, 2015 -- George Chamberlin speaks with Celia Lanning, region president for Wells Fargo, about how Wells Fargo helps communities through charitable efforts, small business lending, and how customer service is still key to Well Fargo's success.








Interview with Marc Doss


	June 29, 2015 -- George Chamberlin speaks with Marc Doss, regional chief investment officer for Wells Fargo Private Bank, about developing successful investment plans.








Interview with Don Clark


	Don Clark, president of Clark Pacific Construction, discusses his company's latest projects, new products and business partnerships that all contribute to helping make Clark Pacific one of the leading design-build precast concrete manufacturers in the United States.


































San Diego Employment




Employment Level
Employment Index
Unemployment Rate
Job Opportunities






Foreclosures




Notices of Default
Trustee Sales






Residential Real Estate




Homes Sales
Mortgage Calculator
Homes for Sale






Commercial Real Estate




Leasing Notes
Commercial Sales
Properties for Sale






New Businesses




Fictitious Business Names Filed
San Diego Business Licenses



















CopyrightPrivacy PolicyAcceptable Use Policy



All contents herein copyright San Diego Source ® 1994-2017






NuVasive Appoints Joan Stafslien as Executive Vice President, General CounselHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreTry Yahoo Finance on Firefox »YahooSearchSearchSign inU.S. Markets closedS&P 5002,472.10-3.32 (-0.13%)Dow 3021,830.31+33.76 (+0.15%)Nasdaq6,374.68-7.51 (-0.12%)NuVasive Appoints Joan Stafslien as Executive Vice President, General CounselMarketwiredOctober 3, 2016ReblogShareTweetShareSAN DIEGO, CA--(Marketwired - October 03, 2016) -  NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced Joan Stafslien is joining the Company as executive vice president, general counsel and corporate secretary. In this role, Ms. Stafslien will oversee the Company's global legal function, reporting to NuVasive's chairman and chief executive officer, Gregory T. Lucier, and serving on the company's executive leadership team.Ms. Stafslien brings to NuVasive more than 20 years of experience as a legal advisor to medical technology companies. She joins NuVasive from CareFusion, where she served as general counsel and corporate secretary from 2009 until its acquisition by Becton Dickinson in 2015."Joan's experience spans a broad spectrum of legal areas, including intellectual property, U.S. and International litigation, regulatory compliance, SEC matters and M&A, with extensive experience in the global medical technology sector," said Mr. Lucier. "Joan's understanding of complex medical technology companies on high growth trajectories makes her a perfect fit with the strong foundation we have established with our legal team. We continue to invest in building a world-class leadership team to support our growing innovation position in the global spine market."Ms. Stafslien's career includes law firm and corporate experience. She previously served as CareFusion's general counsel, corporate secretary and chief compliance officer where she led the legal team through the spin-off from Cardinal Health in 2009 and the acquisition by Becton Dickinson in 2015. Previously, she was the segment general counsel of Cardinal Health's Clinical Technologies and Services from 2004 to 2009. Ms. Stafslien joined Cardinal Health through the acquisition of Alaris Medical Systems in 2004, where she served as deputy general counsel and assistant secretary. Prior to joining Alaris, she was in private practice with Brobeck, Phleger & Harrison. Ms. Stafslien serves on the advisory board of the Chemical and Biological Engineering Department of Northwestern University. She holds a law degree from University of Wisconsin Law School and a bachelor's degree in Chemical Engineering from Northwestern University.About NuVasiveNuVasive, Inc. (NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive's highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $811 million in revenues (2015), NuVasive has an approximate 1,900 person workforce in more than 40 countries around the world. For more information, please visit nuvasive.com.Forward-Looking StatementsNuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextThe Senate probe into big pharma's hand in the opioid crisis just got biggerBusiness InsiderEngineer Finds Pattern; Makes Millions in StocksMoney MorningSponsoredThe real reason overseas manufacturing is coming to AmericaYahoo FinanceThe 'two pizza rule' is a secret to productive meetings that helped Amazon CEO Jeff Bezos become one of the world's richest menBusiness InsiderTax cuts just got more likelyYahoo FinanceDiscover it: 4.8 out of 5 avg. by 24K+ customersDiscover CardSponsoredChevron and Exxon Mobil have a tough path ahead: NYSE traderYahoo Finance VideoStocks mixed after heavy earnings weekNorth Korea 2nd ICBM test puts much of US in range: expertsAssociated PressPeople in Heavy Debt May Be in For a Big SurpriseFreedom Debt ReliefSponsoredAPNewsBreak: Yellowstone to punish workers for misconductAssociated PressSean Hannity responds to claim he ran up a $42,000 tab at Trump's hotel after flying in a 70-year-old lobster from MaineBusiness InsiderMy bullish view on stocks hasn't changed one iota: NYSE traderYahoo Finance VideoWhy You Should Never Buy OptionsInvesting DailySponsoredFast food chains are coping with their labor cost problemYahoo FinanceThe 37 Most Profitable Markets for Home SellersCredit.comMcConnell lashes out at GOP defectors, Democrats in aftermath of 'disappointing' health care voteliberaltroll10: McConnell is a petty, power hungry little man that got the DEFEAT HE so richly DESERVES.Join the Conversation1 / 55.1k








